GlaxoSmithKline Pharma’s Q3 net rises 4%

09 Nov 2012 Evaluate

GlaxoSmithKline Pharmaceuticals has reported results for third quarter ended September 30, 2012.

The company has reported 4.44% rise in its net profit from ordinary activities at Rs 152.34 crore for the quarter ended September 30, 2012 as compared to Rs 145.86 crore for the same quarter in the previous year. Total income of the company has increased by 9.93% at Rs 716.37 crore for quarter under review as compared to Rs 651.68 crore for the quarter ended September 30, 2011.

GlaxoSmithKline Pharmaceuticals is one oldest pharmaceutical company in India. Internationally it has created many brands such as Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax, among others. It employs 5,000 people and has turnover of more than $1 billion in India.

Glaxosmithkline Phar Share Price

2532.85 -10.25 (-0.40%)
08-Dec-2025 15:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1790.05
Dr. Reddys Lab 1272.70
Cipla 1498.90
Zydus Lifesciences 924.35
Lupin 2061.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×